Jheon Sanghoon, Ahmed Aneez Db, Fang Vincent Wt, Jung Woohyun, Khan Ali Zamir, Lee Jang-Ming, Sihoe Alan Dl, Thongcharoen Punnarerk, Tsuboi Masahiro, Turna Akif, Nakajima Jun
Department of Cardiothoracic Surgery, Seoul National University Bundang Hospital, Bundang, South Korea.
Division of Thoracic Surgery, Department of General Surgery, Tan Tock Seng Hospital, Singapore.
Asian Cardiovasc Thorac Ann. 2020 Jul;28(6):322-329. doi: 10.1177/0218492320940162. Epub 2020 Jul 1.
Healthcare resources have been mobilized to combat the COVID-19 pandemic of 2020. The Thoracic Domain of the Asian Society for Cardiovascular and Thoracic Surgery reports a consensus statement on the provision of thoracic cancer surgery during this pandemic.
A Thoracic Experts Panel was convened by the Society. A consensus on the provision, safety, and setting of thoracic cancer surgery during the pandemic was obtained through a Delphi process.
Responses were received from 26 panel members (96% response rate) from 10 regions across Asia. The Society recommended that elective thoracic cancer surgery services may need to be reduced or postponed if medical resources were needed for COVID-19 patients, especially intensive care unit beds and ventilators. However, thoracic cancer surgery should proceed as normal for all solid tumors, without restrictions based on disease stage, availability of non-surgical treatment options, or patient condition (unless there is a high likelihood of postoperative intensive care unit stay). Aerosol-forming procedures should be avoided intra- and perioperatively. The surgical approach does not make a difference in terms of safety. Services for thoracic cancer patients should be offered only in hospitals that maintain isolation wards for patients with confirmed or suspected COVID-19.
Services for patients with thoracic cancer should be maintained during the COVID-19 pandemic. The position of the Society is that thoracic surgeons have a responsibility to perform good surgical management of thoracic cancer during the pandemic, to advocate for patients' rights to receive it, and to safeguard patients and staff from infection.
已调动医疗资源抗击2020年的新冠疫情。亚洲心血管和胸外科协会胸外科领域发布了关于在此次疫情期间提供胸外科癌症手术的共识声明。
该协会召集了一个胸外科专家小组。通过德尔菲法就疫情期间胸外科癌症手术的提供、安全性和环境达成了共识。
收到了来自亚洲10个地区的26名小组成员的回复（回复率为96%）。该协会建议，如果新冠患者需要医疗资源，特别是重症监护病房床位和呼吸机，择期胸外科癌症手术服务可能需要减少或推迟。然而，对于所有实体瘤，胸外科癌症手术应正常进行，不受疾病阶段、非手术治疗选择的可用性或患者状况的限制（除非术后有很高的重症监护病房停留可能性）。应在术中和围手术期避免产生气溶胶的操作。手术方式在安全性方面没有差异。胸外科癌症患者的服务应仅在为确诊或疑似新冠患者设有隔离病房的医院提供。
在新冠疫情期间应维持胸外科癌症患者的服务。该协会的立场是，胸外科医生有责任在疫情期间对胸外科癌症进行良好的手术管理，倡导患者接受手术的权利，并保护患者和工作人员免受感染。
